Karen Kroeker

Associate Professor, Faculty of Medicine & Dentistry - Medicine Dept

Contact Overview Publications

Contact

Associate Professor, Faculty of Medicine & Dentistry - Medicine Dept

Email: kkroeker@ualberta.ca

Overview

Area of Study / Keywords

Ulcerative colitis Colectomy Crohn's Disease Surgery Intestinal Resection Crohn's Pediatric Transition IBD Vitamin D Biologics Registry Biologics Mindfulness Mindfulness Qualitative Research

About

Dr. Karen I. Kroeker is an Associate Professor of Medicine at the University of Alberta. After receiving her BSc (Zoology and Cellular, Molecular, and Microbial Biology) from the University of Calgary, she worked in a medical research laboratory for 2 years. She subsequently received her medical degree from the University of Calgary in 2004. She completed 3 years of internal medicine residency at the University of British Columbia in Vancouver, BC. Following the completion of her gastroenterology residency at the University of Alberta (2009), she completed an Advanced Clinical & Research Fellowship in Inflammatory Bowel Disease (IBD). She received her Masters of Experimental Medicine at the University of Alberta in 2012.

Dr. Kroeker joined the Faculty of Medicine at the University of Alberta in 2010. She is a member of the Active Medical Staff at the University of Alberta Hospital. She has a large practice of patients with inflammatory bowel disease and runs a pediatric IBD transition clinic.

Research

Her research interests inflammatory bowel disease (IBD) patient outcomes, pediatric transition IBD, and clinical care pathways.

Teaching

Dr. Karen Kroeker served as the Gastroenterology Residency Program Director from July 2015 until June 2022. She is actively involved in the teaching of residents and fellows in gastroenterology and inflammatory bowel disease and previously served as the Advanced Inflammatory Bowel Disease Fellowship Director from 2011-2015.

Featured Publications

Multimodal intervention to improve the transition of patients with inflammatory bowel disease from pediatric to adult care: protocol for a randomized controlled trial

Bollegala N., Barwick M., Fu N., Griffiths A.M., Keefer L., Kohut S.A., Kroeker K.I., Lawrence S., Lee K., Mack D.R., Walters T.D., de Guzman J., Tersigni C., Miatello A., Benchimol E.I.

BMC GASTROENTEROLOGY. 2022 May; 22 (1):251 10.1186/s12876-022-02307-9

Predicting transition success in young adults with inflammatory bowel disese: results form a retrospective medical chart review.

Gastroenterology. 2022 May;

Incidence and prevalence of primary sclerosing cholangitis: a meta-analysis of population-based studies

Gastroenterology. 2022 May;

Canadian consensus statements on the transition of adolescent and young adults with inflammatory bowel disease from pediatric to adult care: A collaborative initiative between the Canadian IBD transition network and Crohn's and Colitis Canada

N Fu, N Bollegala, K Jacobson, K Kroeker, K Frost, W Afif, , W El-Matary, S Fowler, A Griffiths, H Huynh, P Jantchou, A Karimuddin, G Nguyen, A Otley, C Pears, C Seow, A Toulany, C Tersigni, J Tignanelli, J Marshall, M Boctor, T Hansen, C Pattni, A Wong, E Benchimol

J Can Gastroenterololgy. 2022 March; 10.1093/jcag/gwab050

Comparing Cortiment and prednisone in ulcerative colitis: a population-based study of outcomes

Journal of the Canadian Association of Gastroenterology. 2022 March;

Defining Transition Success for Young Adults with Inflammatory Bowel Disease According to Patients, Parents and Health Care Providers

A Bihari, N Hamidi, C Seow, K Goodman, E Wine, K Kroeker

J Can Gastroenterology. 2022 March; 5 (4):192-98 10.1093/jcag/gwac004

Exploring patient perspectives on a 12-week, online, stress reduction intervention in inflammatory bowel disease

Journal of the Canadian Association of Gastroenterology. 2022 March;

Molecular analysis of the injury-repair response in ulcerative colitis reveals heterogeneity in disease activity

Journal of the Canadian Association of Gastroenterology. 2022 March;

Predicting transition success in young adults with inflammatory bowel disease: preliminary results

Journal of Canadian Association of Gastroenterology. 2022 March;

The effectiveness of usteskinumab dose escalation in patients with ulcerative colitis

Journal of the Canadian Association of Gastroenterology. 2022 March;

Ulcerative colitis disease activity is dominated by innate immunity and features of tissue remodeling

Journal of the Canadian Association of Gastroenterology. 2022 March;

Usefulness of a novel smartphone app in gastrointestinal endoscopy to track procedure numbers and therapeutic interventions

Journal of the Canadian Association of Gastroenterology. 2022 March;

Breastfeeding patterns in mothers with inflammatory bowel disease: A pilot prospective longitudinal study

P Tandon, E Lee, R Jogendran, K Kroeker, L Dieleman, B Halloran, K Wong, K Berga, V Huang

INFLAMMATORY BOWEL DISEASES. 2022 January; Online ahead of print 10.1093/ibd/izab354

The impact of the COVID-19 pandemic on IBD care in Alberta: patient and provider perspectives

M Dahiya, L Olayinka, G Kaplan, L Reeb, C Ma, R Panaccione, K Kroeker

Journal of the Canadian Association of Gastroenterology. 2022 January; 10.1093/jcag/gwab042

Defining Transition Success in Inflammatory Bowel Disease According to Patient, Parents, and Health Care Providers.

ACG 2021 - Annual Scientific Meeting. 2021 October;

Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or Ustekinumab

Hu A., Kotze P.G., Burgevin A., Tan W., Jess A., Li P.S., Kroeker K., Halloran B., Panaccione R., Peyrin-Biroulet L., Ma C., Ananthakrishnan A.N.

Clinical Gastroenterology and Hepatology. 2021 July; 19 (7):1366-1376.e2 10.1016/j.cgh.2020.07.012

Inflammatory Bowel Disease: A Gastrointestinal Presentation of Congenital Plasminogen Deficiency

Balram B, Thiesen A, Kroeker KI

ACG Case Report J. . 2021 June; 8 (5):e00613 10.14309/crj.0000000000000613

. Impact of COVID-19 Pandemic in IBD Patient Care

Gastroenterology. 2021 May;

Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease

Tandon P., Lee E.Y., Maxwell C., Hitz L., Ambrosio L., Dieleman L., Halloran B., Kroeker K., Huang V.M.

Digestive Diseases and Sciences. 2021 May; 66 (5):1639-1649 10.1007/s10620-020-06381-5

Healthcare Provider Satisfaction with Virtual Care Delivery in Alberta during the COVID-19 Pandemic

Gastroenterology. 2021 May;